Nilvadipine has been demonstrated to increase blood flow to the hippocampus among people with Alzheimer’s disease, according to a recent study.
In a revolutionary approach, Cognetivity (London, UK) have created a new test for detecting dementia and Alzheimer’s disease by focusing on image cognition and the brain’s ability to analyze visual information.
Couldn’t attend the Alzheimer’s Society ‘United Against Dementia Annual Conference’ 2019? Our Editor, Sharon Salt, provides her key highlights from the two-day event here.
In a recent study, researchers have discovered a possible link between high LDL cholesterol and early-onset Alzheimer’s disease.
New guidelines from the World Health Organization recommend specific interventions for reducing the risk of dementia and cognitive decline.
Whilst at the ARUK Conference 2019, we had the pleasure of speaking with Hugh Perry about neuroinflammation and Alzheimer’s disease, particularly the role of microglia in brain homeostasis.
Researchers have identified a cause of dementia with similar symptoms to Alzheimer’s disease; this development could improve diagnosis and treatment of dementia.
Home technology including artificial intelligence, robotics and sleep monitoring may become standard in the homes of people living with dementia, researchers indicate.
To mark World Parkinson’s Day, we’re taking the opportunity to look back on some of the research highlights in the field over the last year.
Couldn’t attend the AD/PD™ 2019 Congress? Our Editor, Sharon Salt, provides her key highlights and takeaway messages from the event.